Fresenius Kabi Oncology Limited Busulfan Export Data — India (DGFT 2022–2026)

Name: Fresenius Kabi Oncology Limited Busulfan Export Records India — #3 Exporter, 77 Shipments, $627.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Busulfan

India Pharmaceutical Trade Intelligence

$4.9M33 Suppliers44 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM25.9%India → PERU15.4%

ImportsUNITED STATES → India$25.5K BRAZIL → India$3.3K

#1 Supplier: INTAS PHARMACEUTICALS

Fresenius Kabi Oncology Limited — Busulfan Exporter #3 | $627.6K Trade Value | TransData Nexus | TransData Nexus

Fresenius Kabi Oncology Limited — Busulfan Exporter Profile

Indian Pharmaceutical Exporter · #3 for Busulfan · $627.6K export value · DGFT Verified

Fresenius Kabi Oncology Limited is the #3 Indian exporter of Busulfan with $627.6K in export value and 77 verified shipments. Fresenius Kabi Oncology Limited holds a 12.7% market share in Busulfan exports across 7 countries. The company exports 16 pharmaceutical products worth $117.2M across 3 therapeutic categories.

Fresenius Kabi Oncology Limited — Busulfan Export Profile: Buyers & Destinations

Fresenius Kabi Oncology Limited Busulfan export treemap — buyers and destination countries | TransData Nexus

Where Does Fresenius Kabi Oncology Limited Export Busulfan?

Country	Value	Shipments	Share
GERMANY	$463.2K	67	74.6%
URUGAY	$50.0K	1	8.0%
SOUTH AFRICA	$50.0K	1	8.0%
EGYPT	$26.5K	1	4.3%
MALAYSIA	$22.9K

Who Are the Top Buyers of Busulfan from Fresenius Kabi Oncology Limited?

Buyer	Country	Value	Orders
FRESENIUS KABI DEUTSCHLAND GMBH	GERMANY	$426.4K	60
RINQUE PHARMA S A	URUGAY	$50.0K	1
FRESENIUS KABI SOUTH AFRICA (PTY) L	SOUTH AFRICA	$50.0K	1
FRESENIUS KABI DEUTSCHLAND GMB	GERMANY	$36.8K	7
THE EGYPTIAN PHARMACEUTICAL TRADING	EGYPT	$26.5K	1
FRESENIUS KABI MALAYSIA SDN BHD	MALAYSIA	$18.6K	4
BRANCH OF ZUELLIG PHARMA VIETNAM LT	VIETNAM, DEMOCRATIC REP. OF	$4.4K	1
FRESENIUS KABI MALAYSIA SDN BHD.	MALAYSIA	$4.2K	1
FRESENIUS KABI (THAILAND) LTD	THAILAND	$4.1K	1

Fresenius Kabi Oncology Limited supplies Busulfan to 9 buyers globally. The largest buyer is FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), followed by RINQUE PHARMA S A (URUGAY) and FRESENIUS KABI SOUTH AFRICA (PTY) L (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Busulfan Formulations Does Fresenius Kabi Oncology Limited Export?

Product Description / Formulation	Value	Shipments
BUSULFAN FRESENIUS KABI INJECTION 60MG/1	$144.9K	25
BUSULFANO FRESENIUS KABI INJECTION 60MG 10ML VIAL BATCH NO 87230016AE MFG DT 01 2023 EXP DT 12 2024	$50.0K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML BATCH NO. 87230476AF MFG. DT. 11/2023 EXP. DT. 10/2025	$50.0K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML B	$46.6K	8
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML BATCH NO. 87220441AH MFG. DT. 11/2022 EXP. DT. 10/2024	$26.5K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML (BATCH NO. 87250104AA MFG. DT. 03/2025 EXP. DT. 02/2027)	$19.5K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML BATCH NO 87230391AA, MANUFACTURING . DT. 08/2023, EXP. DT. 07/2025	$19.3K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML (BATCH NO. 87250105AA MFG. DT. 03/2025 EXP. DT. 02/2027)	$16.8K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML (BATCH NO. 87250105AD MFG. DT. 03/2025 EXP. DT. 02/2027)	$14.8K	1
BUSULFAN FRESENIUS KABI INJ. 60MG/10ML (BATCH NO. 87250104AB MFG. DT. 03/2025 EXP. DT. 02/2027)	$14.7K	1

Fresenius Kabi Oncology Limited exports 45 distinct Busulfan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BUSULFAN FRESENIUS KABI INJECTION 60MG/1 with 25 shipments worth $144.9K.

How Does Fresenius Kabi Oncology Limited Compare to Nearest Busulfan Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED	$2.0M	92	15	$21.7K
2	EMCURE PHARMACEUTICALS LIMITED	$1.5M	109	9	$14.1K
3	FRESENIUS KABI ONCOLOGY LIMITED ★	$627.6K	77	7	$8.2K
4	INTAS PHARMACEUTICALS LTD	$324.7K	16	5	$20.3K
5	SHILPA MEDICARE LIMITED	$150.5K	5	4	$30.1K

Fresenius Kabi Oncology Limited ranks #3 among 33 Indian Busulfan exporters. Average shipment value of $8.2K compared to the market average of $143.5K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Busulfan Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	75	20.3%
SAHAR AIR	62	16.8%
DELHI AIR	41	11.1%
DELHI AIR CARGO ACC (INDEL4)	31	8.4%
AHEMDABAD AIR ACC (INAMD4)	26	7.0%
AHEMDABAD AIR	21	5.7%
MUNDRA SEA (INMUN1)	17	4.6%
Ahmedabad Air	13	3.5%

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Busulfan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like FKOL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased freight charges and extended transit times, posing significant risks to time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs on Chinese goods, including pharmaceuticals, prompting American importers to seek alternative suppliers. This shift has benefited Indian exporters, as evidenced by the U.S. accounting for approximately 34.5% of India's pharma exports, valued at around $10.5 billion. (actizaindustry.com) However, the U.S. administration's fluctuating tariff policies, including threats of increased tariffs on pharmaceutical imports, necessitate vigilance and adaptability from exporters like FKOL. (lemonde.fr)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent requirements on pharmaceutical imports. Compliance with these regulations demands significant investment in serialization and traceability systems. For FKOL, ensuring adherence to such standards is crucial to maintaining access to the lucrative EU market and upholding its reputation for quality and reliability.

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the FDA and WHO emphasizing Good Manufacturing Practices (GMP) compliance. Indian exporters, including FKOL, must navigate this evolving landscape to sustain their market positions. Notably, the FDA has increased inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to escalate this number in 2024. (fact.net.in)

FKOL's commitment to quality is evident in its state-of-the-art Research & Development center in Gurgaon, India. The facility focuses on developing next-generation cytotoxic and cytostatic therapies, ensuring that products meet the highest quality standards irrespective of the target market. (fresenius-kabi-oncology.com) This proactive approach to quality assurance positions FKOL favorably in a competitive and regulated global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Busulfan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fresenius Kabi Oncology Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 77 individual customs records matching Fresenius Kabi Oncology Limited exporting Busulfan, covering 45 formulations to 7 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 109+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Busulfan

Busulfan

Fresenius Kabi Oncology Limited — Busulfan Exporter Profile

Fresenius Kabi Oncology Limited — Busulfan Export Profile: Buyers & Destinations

Where Does Fresenius Kabi Oncology Limited Export Busulfan?

Who Are the Top Buyers of Busulfan from Fresenius Kabi Oncology Limited?

What Is India's Total Busulfan Export Value and How Much Does Fresenius Kabi Oncology Limited Contribute?

What Is the Average Shipment Value for Fresenius Kabi Oncology Limited's Busulfan Exports?

How Does Fresenius Kabi Oncology Limited Compare to Other Indian Busulfan Exporters?

What Busulfan Formulations Does Fresenius Kabi Oncology Limited Export?

Regulatory Requirements: Exporting Busulfan to Key Markets

Germany — BfArM/EMA

South Africa — SAHPRA

How Does Fresenius Kabi Oncology Limited Compare to Nearest Busulfan Exporters?

Which Indian Ports Ship Busulfan Exports?

What Other Advanced Oncology Products Does Fresenius Kabi Oncology Limited Export?

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Busulfan Exports

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

About Fresenius Kabi Oncology Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Busulfan Export Data from Fresenius Kabi Oncology Limited

Busulfan Stats

Company Overview

Top Products by Fresenius Kabi Oncology Limited

Related Analysis

Need Detailed Export Data?

Data Source